Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)

AIM: To compare the associations between concomitant liraglutide use versus no liraglutide use and the risk of major adverse cardiovascular events (MACE) and all‐cause mortality among patients receiving basal insulin (either insulin degludec [degludec] or insulin glargine 100 units/mL [glargine U100...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Brown‐Frandsen, Kirstine, Emerson, Scott S., McGuire, Darren K., Pieber, Thomas R., Poulter, Neil R., Pratley, Richard E., Zinman, Bernard, Ranthe, Mattis F., Grøn, Randi, Lange, Martin, Moses, Alan C., Örsy, Petra, Buse, John B.
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6504564/
https://ncbi.nlm.nih.gov/pubmed/30793465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13677
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars